BehaveNet^® Clinical Capsule™:

drug: biperiden

• Clinical class: Anti-Parkinsonian
• Psychiatric uses: to counteract medication-induced movement disorders
• Action: anticholinergic
• CSA schedule: none
• DEA number: none

U.S. Preparations:

• Akineton^® (Abbott Laboratories) FDA approved for treatment of: adjunctive treatment of parkinsonism; extrapyramidal syndrome adverse effects of dopamine antagonist antipsychotic drugs

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2006 BehaveNet®